Skip to search formSkip to main contentSkip to account menu

pegamotecan

Known as: PEG-camptothecin, PEG-beta-camptothecin, PEG-beta-CPT 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

CamptothecinPolyethylene Glycols

Narrower (1)

Prothecan
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study…
4030 Background: The results of a phase 1 study of pegamotecan have been published.1 This phase 2 study was designed to evaluate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)